Bacteria: Gram-positive

Enterococcus faecium

General medical information for education only, not medical advice. Treatment considerations summarize published guidance at drug-class level; therapy is chosen by the treating clinician using susceptibility results, local resistance patterns and current guidelines.

Overview

A gut enterococcus and the species most often resistant to vancomycin (VRE).

Infections

Healthcare-associated urinary tract, bloodstream and intra-abdominal infection.

Signs and symptoms

Usually healthcare-associated. Bloodstream infection, often linked to a catheter: fever and chills. Urinary infection in catheterized patients: fever and flank or suprapubic pain. Intra-abdominal and wound infection: pain, swelling and fever. Endocarditis: prolonged fever, fatigue and a new heart murmur. Intestinal carriage of vancomycin-resistant strains causes no symptoms.

Antibiotic and antimicrobial resistance

Usually ampicillin-resistant; vanA or vanB (vanA/vanB) cause vancomycin resistance (VRE).

Treatment considerations

Guided by susceptibility testing; linezolid or daptomycin for VRE; nitrofurantoin or fosfomycin may be options for cystitis.

Infection control and public health

VRE: contact precautions per facility policy.

Purple Gram-positive Enterococcus faecium cocci in pairs and chains
Enterococcus faecium, Gram stain of culture. A. K. Chaurasiya; CC0. Image source
Gram-positive cocci in pairs and chains, schematic
Gram-positive cocci in pairs and chains. Schematic, not to scale; InnovexLab.

Sources

  1. CDC. Vancomycin-resistant Enterococci (VRE).
  2. CDC. Antimicrobial Resistance: Threats and data.

Sources accessed November 2026. Links open external sites that InnovexLab does not control.

Medical disclaimer

This page is general educational information summarized from published public-health and professional-society guidance. It is not medical advice, a diagnosis or a treatment recommendation, and reading it does not create a clinician–patient relationship with InnovexLab. Decisions about testing, diagnosis and treatment belong to the treating clinician, using the patient’s history and examination, laboratory and susceptibility results, local resistance patterns and current guidelines. Guidance changes over time; consult the original sources for the latest version. InnovexLab provides this information as is and does not warrant that it is complete or current.

Patients with questions about their health should contact their own healthcare provider. In an emergency, call 911.

Sources, image credits and editorial policy

Discuss a testing program with InnovexLab

Review the panel that fits your patients, its specimen requirements, and how results and billing work.